Targeting Cardiac Fibrosis With a Vaccine Against Fibroblast Activation Protein

Affiliations

Editorial

William M Oldham. Circ Res. 2025.

. 2025 Jan 3;136(1):41-43.

doi: 10.1161/CIRCRESAHA.124.325804. Epub 2025 Jan 2.

¹ Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

No abstract available

Keywords: Editorials; cardiomyopathies; fibrosis; hypertension; obesity.

Conflict of interest statement

None.

A Vaccine Against Fibroblast Activation Protein Improves Murine Cardiac Fibrosis by Preventing the Accumulation of Myofibroblasts.
Yoshida S, Hayashi H, Kawahara T, Katsuki S, Kimura M, Hino R, Sun J, Nakamaru R, Tenma A, Toyoura M, Baba S, Shimamura M, Katsuya T, Morishita R, Rakugi H, Matoba T, Nakagami H. Yoshida S, et al. Circ Res. 2025 Jan 3;136(1):26-40. doi: 10.1161/CIRCRESAHA.124.325017. Epub 2024 Dec 4. Circ Res. 2025. PMID: 39629565 Free PMC article.

1. Frangogiannis NG. Cardiac fibrosis. Cardiovasc Res. 2021;117:1450–1488. - PMC - PubMed
1. González A, Schelbert EB, Díez J, Butler J. Myocardial Interstitial Fibrosis in Heart Failure: Biological and Translational Perspectives. J Am Coll Cardiol. 2018;71:1696–1706. - PubMed
1. Kaur H, Takefuji M, Ngai CY, Carvalho J, Bayer J, Wietelmann A, Poetsch A, Hoelper S, Conway SJ, Möllmann H, et al. Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice. Circ Res. 2016;118:1906–1917. - PubMed
1. Kanisicak O, Khalil H, Ivey MJ, Karch J, Maliken BD, Correll RN, Brody MJ, J Lin S-C, Aronow BJ, Tallquist MD, et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat Commun. 2016;7:12260. - PMC - PubMed
1. Aghajanian H, Kimura T, Rurik JG, Hancock AS, Leibowitz MS, Li L, Scholler J, Monslow J, Lo A, Han W, et al. Targeting cardiac fibrosis with engineered T cells. Nature. 2019;573:430–433. - PMC - PubMed